Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 12, 2024

BUY
$73.27 - $83.09 $7,327 - $8,309
100 New
100 $8,000
Q2 2022

Jul 12, 2022

SELL
$57.72 - $65.01 $2,020 - $2,275
-35 Closed
0 $0
Q1 2022

Apr 25, 2022

BUY
$57.92 - $72.58 $2,027 - $2,540
35 New
35 $2,000
Q1 2021

Apr 12, 2021

SELL
$60.0 - $68.46 $3,000 - $3,422
-50 Closed
0 $0
Q4 2020

Jan 19, 2021

BUY
$56.65 - $64.55 $2,832 - $3,227
50 New
50 $2,000
Q4 2019

Jan 10, 2020

SELL
$61.62 - $67.78 $5,299 - $5,829
-86 Closed
0 $0
Q3 2019

Oct 25, 2019

SELL
$62.51 - $69.0 $61,447 - $67,827
-983 Reduced 91.96%
86 $5,000
Q2 2019

Jul 24, 2019

BUY
$61.87 - $69.38 $66,139 - $74,167
1,069 New
1,069 $72,000
Q4 2018

Jan 22, 2019

SELL
$60.54 - $79.0 $33,236 - $43,371
-549 Closed
0 $0
Q3 2018

Oct 29, 2018

BUY
$71.28 - $78.92 $39,132 - $43,327
549 New
549 $42,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.